Search Results - "Villanueva, Joyce M."

Anti–IL-5 (mepolizumab) therapy reduces eosinophil activation ex vivo and increases IL-5 and IL-5 receptor levels by Stein, Miguel L., MD, Villanueva, Joyce M., BS, Buckmeier, Bridget K., BA, Yamada, Yoshiyuki, MD, Filipovich, Alexandra H., MD, Assa'ad, Amal H., MD, Rothenberg, Marc E., MD, PhD

“…Background Anti–IL-5 might be a useful therapeutic agent for eosinophilic disorders, yet its immunologic consequences have not been well characterized…”
Get full text

Anti–IL-5 (mepolizumab) therapy for eosinophilic esophagitis by Stein, Miguel L., Collins, Margaret H., Villanueva, Joyce M., Kushner, Jonathan P., Putnam, Philip E., Buckmeier, Bridget K., Filipovich, Alexandra H., Assa'ad, Amal H., Rothenberg, Marc E.

“…Eosinophilic esophagitis (EE) is characterized by high numbers of eosinophils in the esophagus and epithelial hyperplasia, and is being increasingly…”
Get full text

Anti–interleukin-5 (mepolizumab) therapy for hypereosinophilic syndromes by Garrett, Jennifer K, Jameson, Sean C, Thomson, Blythe, Collins, Margaret H, Wagoner, Lynne E, Freese, Debbie K, Beck, Lisa A, Boyce, Joshua A, Filipovich, Alexandra H, Villanueva, Joyce M, Sutton, Steven A, Assa'ad, Amal H, Rothenberg, Marc E

“…IL-5 is a cytokine critically involved in regulating several aspects of eosinophils including their production, activation, and tissue recruitment. As such,…”
Get full text

Interplay of Adaptive Th2 Immunity with Eotaxin‐3/C‐C Chemokine Receptor 3 in Eosinophilic Esophagitis by Bullock, Jennifer Z, Villanueva, Joyce M, Blanchard, Carine, Filipovich, Alexandra H, Putnam, Philip E, Collins, Margaret H, Risma, Kimberly A, Akers, Rachel M, Kirby, Cassie L, Buckmeier, Bridget K, Assa'ad, Amal H, Hogan, Simon P, Rothenberg, Marc E

“…ABSTRACT Background: Pediatric eosinophilic esophagitis (EE) is a recently described disorder associated with atopy. Although studies of esophageal tissue…”
Get full text